Research analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued on Sunday. The brokerage set a “hold” rating on the medical ...
$CTSO insiders have traded $CTSO stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback